Inflammatory bowel disease (IBD), including the Crohn´s disease, is one of the most important civilization disorder nowadays. Algae4IBD’s mission is to discover algal and cyanobacterial bioactive compounds reducing the inflammatory response and simultaneously silencing other IBD symptoms. The biomass of algal strains producing such compound will be used for preparation of functional food used in treatment and prevention of IBD. International consortium led by Israeli colleagues includes scientist from 21 European institutions with different expertise ranging from natural product chemistry, pharmacology, drug administration to functional food preparation.